It appears that this may not occur during 2018. They are still looking for an appropriate project and funding. Funds are tight. I guess we should be thankful that accounts have been cleaned up after the mess they were in. See you in 2019 guys.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%